{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:42:16Z","timestamp":1788835336374,"version":"build-2803163510"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00066-024-02256-0","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T20:41:46Z","timestamp":1719952906000},"page":"983-985","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tolerance of radiotherapy with concomitant glofitamab in diffuse large B\u00a0cell lymphoma: a\u00a0case report"],"prefix":"10.1007","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-8110","authenticated-orcid":false,"given":"Pierre","family":"Loap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Birsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Decroocq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"issue":"24","key":"2256_CR1","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa2206913","volume":"15;387","author":"MJ Dickinson","year":"2022","unstructured":"Dickinson\u00a0MJ, Carlo-Stella\u00a0C, Morschhauser\u00a0F, Bachy\u00a0E, Corradini\u00a0P, Iacoboni\u00a0G et\u00a0al (2022) Glofitamab for Relapsed or Refractory Diffuse Large B\u2011Cell Lymphoma. N\u00a0Engl J Med 15;387(24):2220\u20132231 (Dec)","journal-title":"N Engl J Med"},{"issue":"3","key":"2256_CR2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ijrobp.2017.12.005","volume":"1;100","author":"AK Ng","year":"2018","unstructured":"Ng\u00a0AK, Yahalom\u00a0J, Goda\u00a0JS, Constine\u00a0LS, Pinnix\u00a0CC, Kelsey\u00a0CR et\u00a0al (2018) Role of Radiation Therapy in Patients With Relapsed\/Refractory Diffuse Large B\u2011Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol 1;100(3):652\u2013669 (Mar)","journal-title":"Int J Radiat Oncol"},{"issue":"5","key":"2256_CR3","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41409-020-01156-y","volume":"56","author":"I Danylesko","year":"2021","unstructured":"Danylesko\u00a0I, Shouval\u00a0R, Shem-Tov\u00a0N, Yerushalmi\u00a0R, Jacoby\u00a0E, Besser\u00a0MJ et\u00a0al (2021) Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T\u00a0cells treatment in aggressive B\u2011cell lymphoma. Bone Marrow Transplant 56(5):1134\u20131143 (May)","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2256_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/10428194.2022.2161304","volume":"23;64","author":"C Sortais","year":"2023","unstructured":"Sortais\u00a0C, Cordeil\u00a0S, Bourbon\u00a0E, Idlhaj\u00a0M, Ferrant\u00a0E, Safar\u00a0V et\u00a0al (2023) Flare-up phenomenon or pseudoprogression after CAR T\u2011cell infusion in non-Hodgkin aggressive lymphomas. Leuk Lymphoma 23;64(3):707\u2013711 (Feb)","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2256_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1269\/jrr.46.241","volume":"46","author":"I Skvortsova","year":"2005","unstructured":"Skvortsova\u00a0I, Popper\u00a0BA, Skvortsov\u00a0S, Saurer\u00a0M, Auer\u00a0T, Moser\u00a0R et\u00a0al (2005) Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin\u2019s lymphoma cells. J\u00a0Radiat Res 46(2):241\u2013248 (Jun)","journal-title":"J Radiat Res"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-024-02256-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-024-02256-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-024-02256-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T18:03:23Z","timestamp":1730397803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-024-02256-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":5,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["2256"],"URL":"https:\/\/doi.org\/10.1007\/s00066-024-02256-0","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"assertion":[{"value":"7 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.\u00a0Loap, N.\u00a0Johnson, R.\u00a0Birsen, J.\u00a0Decroocq and Y.\u00a0Kirova declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}